Yuji Kaneoka

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)

Katsuhiko Uesaka, Narikazu Boku, Akira Fukutomi et al. · The Lancet · 2016 · 1.1K citations

Surgical Oncology, Oncology, Pancreatic Cancer +6

Randomized clinical trial of adjuvant gemcitabine chemotherapy <i>versus</i> observation in resected bile duct cancer

Tomoki Ebata, Satoshi Hirano, Masaru Konishi et al. · British journal of surgery · 2018 · 378 citations

Thirty‐six Cases of Obturator Hernia: Does Computed Tomography Contribute to Postoperative Outcome?

Yukihiro Yokoyama, Akihiro Yamaguchi, Masatoshi Isogai et al. · World Journal of Surgery · 1999 · 128 citations

Recurrence after resection with curative intent for distal cholangiocarcinoma

Kenichi Komaya, Tomoki Ebata, K. Shirai et al. · British journal of surgery · 2017 · 118 citations

Prognostic Significance of Simultaneous Measurement of Three Tumor Markers in Patients With Hepatocellular Carcinoma

Hidenori Toyoda, Takashi Kumada, Seiki Kiriyama et al. · Clinical Gastroenterology and Hepatology · 2006 · 109 citations · Full text